ArticleBMC infectious diseases2025
Viral sepsis-induced mortality of older patients infected by the Omicron subvariant BA.5 of SARS-CoV-2: a retrospective study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between Admission Diastolic Blood Pressure and Clinical Outcomes in Elderly Patients with Severe/Critical COVID-19: A Retrospective Cohort Study.International journal of general medicine · 2026Article
- Viral-associated septic shock in pediatric pneumonia: a retrospective analysis of pathogen-specific risks and comparative clinical features with bacterial sepsis.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe infection by the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among the older population induced viral sepsis and put them at high risk of severity and mortality.
methodsWe retrospectively investigated 268 patients infected with the Omicron variant of SARS-CoV-2 and hospitalized in two tertiary medical centers in Jiangsu Province, China, from December 2022 to January 2023, who met the Sepsis- 3 criteria. Patients were divided into the survivor (n = 111) and non-survivor (n = 157) groups, and their baseline clinical characteristics, including their demographic information, medical history, clinical manifestation, laboratory test results, arterial blood gas profiles and computed tomography (CT) patterns, were compared between the two groups to evaluate the risk factors for in-hospital death caused by viral sepsis.
resultsThe median age of the patients hospitalized was 78.5 (IQR: 71.3-84.8), and 69.0% of them were male. 45.9% of the patients were aged ≥ 80 years. From illness onset to hospitalization the median length of time was 7 days, while the duration of hospitalization was 10.0 days (IQR: 6.0-20.8) and the stay in the intensive care unit (ICU) was 7.0 days (IQR: 4.0-14.0). The median cycle threshold (Ct) values for ORF1ab and N gene amplification were 30.3 and 29.2, respectively. Hypertension, diabetes, and cardiovascular diseases prevailed in the patients' comorbidity list. After laboratory parameters, arterial blood gas exchange profiles, and radiological patterns were examined, a substantial impact of multiple organ dysfunctions induced by Omicron subvariant BA.5 infection was observed in both groups. As a result, the Sequential Organ Failure Assessment (SOFA) score was significantly factorial in the in-hospital mortality of older patients with COVID-19 (a fatality rate of 58.6%), consistent with determinants in death from non-viral sepsis.
conclusionWith the Omicron subvariants having lower pathogenicity but higher transmissibility compared to pre-Omicron variant of concern (VOC), the older population remains the most vulnerable to COVID-19 infection, which could lead to sepsis and septic shock, highlighting the importance of timely booster vaccinations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.